MolDX: Molecular Testing for Solid Organ Allograft Rejection

After careful consideration of all the feedback from interested parties regarding the MolDX: Molecular Testing for Solid Organ Allograft Rejection (DL38671) proposed local coverage determination (LCD), we have decided not to finalize the proposed LCD. In the coming months, we intend to issue a new proposed LCD and look forward to further public comment on this very important issue. The Medicare coverage database will be fully updated to reflect this decision next week.

Last Updated Sep 05 , 2024